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Background: Lumbosacral radicular pain is a common cause of chronic low back pain. Despite published reports of effectiveness
of transforaminal epidural steroid for lumbosacral radicular pain, it is underutilised in many tertiary hospitals in sub-Saharan
Africa. This study assessed the clinical effects of transforaminal epidural steroid injections in patients with lumbosacral
radicular pain at a major tertiary health facility in Nigeria.
Methods: This is a prospective observational study carried out between March 2012 and February 2016. Under fluoroscopy, the
epidural space was accessed through the neuroforamen using 22G spinal needles in 47 adult patients with lumbosacral radicular
pain; and a mixture of 10 mg triamcinolone acetonide and 0.25% plain bupivacaine (2 mLs per level) was injected. Pain intensity
and functional impairment were assessed with the Numeric Pain Rating Scale (NPRS) and the Oswestry Disability Index (ODI)
scores respectively at three and six months.
Results: The pain and ODI scores at baseline and at six months’ follow-up improved significantly; 8.49 ± 1.28 vs. 3.6 ± 1.5 (p =
0.002) and 45.1 ± 11.5 vs. 32.4 ± 11.5 (p = 0.001) respectively.
Conclusion: Transforaminal epidural steroid injections provided significant pain relief and improved function in patients with
lumbar radicular pain due to intervertebral disc herniations.
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Introduction
Lumbar radicular pain secondary to lumbar disc herniation is an
important cause of disabling chronic low back pain. The mech-
anism of the pain is due to the inflammation of the affected
nerve roots by the disc contents.1–3 Epidural steroid injections
are one of the most utilised therapeutic interventions for treat-
ment of chronic low back with or without lower extremity
pain4,5 but are rarely offered to patients in most hospitals in
the West African sub-region. Until recently, patients with
chronic low back pain in most African healthcare institutions
were being managed with non-steroidal anti-inflammatory
medications (NSAIMs), bed rest, low-potency opioids and ses-
sions of physiotherapy but without achieving significant pain
relief.6 We evaluated the outcomes of transforaminal epidural
steroid injections, which are believed to guarantee deposition
of the medication closer to the inflamed nerve roots compared
with the traditional interlaminar approach, for lumbosacral radi-
cular pain at a University Teaching Hospital in Nigeria.
Materials and methods
This prospective observational study was carried out in a tertiary
health centre after approval by the institutional ethical review com-
mittee. All the patients were referred from orthopaedic and neuro-
surgical clinics, consented to participate and were enrolled into the
study (from March 2012 to February 2016). Before intervention,
patients were educated on the use of Numeric Pain Rating Scale
(NPRS) for pain and Oswestry Disability Index (ODI) for functional
status. Information on co-morbid medical conditions, previous
history of back surgery and reports of magnetic resonance
imaging (MRI) of the lumbar spine were obtained and recorded.
Patients with presence of lumbosacral radicular pain unrespon-
sive to at least 12 weeks of conservative treatment, pain severity
score of ≥ 5, magnetic resonance imaging of the lumbosacral
spine and intact motor or bladder/bowel function, and the cog-
nitive competence to participate in outcome measurements
were recruited into the study. All the patients had magnetic res-
onance imaging (MRI) of the lumbar spine that confirmed her-
niation of disc(s) at the segmental levels consistent with the
clinical features.
Patients with any of the following conditions were not enrolled
into the study: previous lumbar surgery, uncontrolled psychiatric
disorders, uncontrolled acute or chronic medical illness, local
infection around the back, adverse reactions to local anaesthetic
or steroid, pregnant or lactating women and patients on anticoa-
gulants with a history of chronic low back pain.
Technique of injection
The patients were placed in the prone position on a fluoroscopic
table. The back area was cleaned with povidone iodine and
covered with a sterile drape, which was fenestrated over the
lumbar region. Using the fluoroscope in an AP view, the
pedicle corresponding to the targeted foramen was identified
and the image intensifier was moved in cephalo-caudal direc-
tion until the inferior end plate was seen as a line rather than
an oval, that is the X-ray beam passes tangentially. Then, the
image intensifier was rotated to 20–30o in the oblique position
on the side of the pathology and a 22G spinal needle was
advanced towards the neuroforamen through the skin just
below the 6 o’clock position of the pedicle. The needle advance-
ment was stopped when the tip was subpedicular in the ‘safe tri-
angle’ of the neuroforamen, approximately halfway between the
ventral and dorsal extent of the pedicle when imaged in a true
lateral view. The needle was aspirated for blood or cerebrospinal
fluid (CSF) and a negative aspirate was obtained before a non-
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Introduction
Lumbar radicular pain secondary to lumbar disc herniation is an
important cause of disabling chronic low back pain. The mech-
anism of the pain is due to the inflammation of the affected
nerve roots by the disc contents.1–3 Epidural steroid injections
are one of the most utilised therapeutic interventions for treat-
ment of chronic low back with or without lower extremity
pain4,5 but are rarely offered to patients in most hospitals in
the West African sub-region. Until recently, patients with
chronic low back pain in most African healthcare institutions
were being managed with non-steroidal anti-inflammatory
medications (NSAIMs), bed rest, low-potency opioids and ses-
sions of physiotherapy but without achieving significant pain
relief.6 We evaluated the outcomes of transforaminal epidural
steroid injections, which are believed to guarantee deposition
of the medication closer to the inflamed nerve roots compared
with the traditional interlaminar approach, for lumbosacral radi-
cular pain at a University Teaching Hospital in Nigeria.
Materials and methods
This prospective observational study was carried out in a tertiary
health centre after approval by the institutional ethical review com-
mittee. All the patients were referred from orthopaedic and neuro-
surgical clinics, consented to participate and were enrolled into the
study (from March 2012 to February 2016). Before intervention,
patients were educated on the use of Numeric Pain Rating Scale
(NPRS) for pain and Oswestry Disability Index (ODI) for functional
status. Information on co-morbid medical conditions, previous
history of back surgery and reports of magnetic resonance
imaging (MRI) of the lumbar spine were obtained and recorded.
Patients with presence of lumbosacral radicular pain unrespon-
sive to at least 12 weeks of conservative treatment, pain severity
score of ≥ 5, magnetic resonance imaging of the lumbosacral
spine and intact motor or bladder/bowel function, and the cog-
nitive competence to participate in outcome measurements
were recruited into the study. All the patients had magnetic res-
onance imaging (MRI) of the lumbar spine that confirmed her-
niation of disc(s) at the segmental levels consistent with the
clinical features.
Patients with any of the following conditions were not enrolled
into the study: previous lumbar surgery, uncontrolled psychiatric
disorders, uncontrolled acute or chronic medical illness, local
infection around the back, adverse reactions to local anaesthetic
or steroid, pregnant or lactating women and patients on anticoa-
gulants with a history of chronic low back pain.
Technique of injection
The patients were placed in the prone position on a fluoroscopic
table. The back area was cleaned with povidone iodine and
covered with a sterile drape, which was fenestrated over the
lumbar region. Using the fluoroscope in an AP view, the
pedicle corresponding to the targeted foramen was identified
and the image intensifier was moved in cephalo-caudal direc-
tion until the inferior end plate was seen as a line rather than
an oval, that is the X-ray beam passes tangentially. Then, the
image intensifier was rotated to 20–30o in the oblique position
on the side of the pathology and a 22G spinal needle was
advanced towards the neuroforamen through the skin just
below the 6 o’clock position of the pedicle. The needle advance-
ment was stopped when the tip was subpedicular in the ‘safe tri-
angle’ of the neuroforamen, approximately halfway between the
ventral and dorsal extent of the pedicle when imaged in a true
lateral view. The needle was aspirated for blood or cerebrospinal
fluid (CSF) and a negative aspirate was obtained before a non-
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ionic contrast medium (omnipaque iohexol 240 mg) was
injected under continuous fluoroscopy to confirm proximal
spread and exclude vascular uptake. The injection of the con-
trast was completed in AP view. If vascular uptake was
noticed, the needle tip was repositioned until appropriate con-
trast spread was observed. For the confirmation of anterior epi-
dural spread, a lateral fluoroscopic image was obtained and 2 ml
of a mixture of 10 mg triamcinolone acetonide and 0.25% plain
bupivacaine was injected per affected level with not more than
four levels during a treatment session, Figure 1.
Patients were observed for one hour post-intervention and
assessed for any adverse effects such as nausea, vomiting and
lethargy. At the discretion of the patients, the injection was
repeated once or twice 10–14 days after the last injection in
order to boost the response. Patients were sent for physiother-
apy after the interventions.
Patients who reported at least 2 points reduction in their pain
intensity after the treatment were followed up and assessed at
3 and 6 months after the last injection. The outcome measures
were NPRS and ODI scores; and the proportion of patients
who attained clinically relevant success in terms of pain relief
and functional status were determined. The quantity of analge-
sic consumption was also assessed at the end of the six months’
follow-up. Clinically relevant treatment success was deemed to
have been achieved when patients reported a drop in the
NPRS score ≥ 2.5 or a reduction in the ODI score of 10 or
greater.7,8
Data analysis
Data analyses were carried out using SPSS® software for
Windowa (version 20.0, SPSS Inc, Chicago, IL, USA). Data on base-
line features and outcomes were collected and recorded. Means
and standard deviations were calculated for continuous vari-
ables that described outcomes in the treated patients at base-
line, three and six months. Results for proportions are reported
as percentages and nonparametric tests were applied when
the data obtained were not normally distributed. For compari-
sons of baseline values with the parameters obtained after the
intervention, a paired t-test was used; a p-value of < 0.05 was
considered to be statistically significant.
Results
A total of 68 patients diagnosed with lumbosacral radicular pain
received transforaminal epidural steroid injections. After the first
injection and prior to assessing their response to the treatment,
21 patients were excluded from this study due to geographical
relocations and co-morbid depressive disorder (19 vs. 2 patients,
respectively). The remaining 47 patients, 26 males (55.3%) and
21 (44.7%) females, who completed the study were analysed.
The mean age, weight and height of the patients were 58.2 ±
11.6 years, 78.5 ± 8.2 kg and 1.68 ± 0.02 m respectively. The
mean duration of pain before the patients were offered the
treatment was 4.5 ± 4.7 months and the sites of radicular pain
affected the left lower limb, both lower limbs and right lower
limb in 8 (17%), 15 (31.9%) and 24 (51.1%) patients respectively
(Table 1).
The lumbar spine MRI showed disc herniation at more than one
intervertebral level in 39 (83%) patients and only 8 (17%)
patients had single-level disc herniation. Prior to intervention,
pain intensities were of severe and moderate scores respectively
in 45 (94%) and 2 (4%) of the patients evaluated. Similarly, 21
(45%) patients were observed to be functionally compromised
with ODI of severe and moderate scores respectively.
The mean score of the NPRS for pain and ODI score were 8.5 ±
1.3 and 45.1 ± 11.5 respectively at first presentation. The com-
monest co-morbid medical condition was hypertension in 15
patients, with an incidence of 31.9% (see Table 1).
The most injected nerve roots were L4 and L5, and the transfor-
aminal epidural steroid injections were given to 29 (61.7%), 13
(27.7%) and 5 (10.6%) patients once, twice or three times
Figure 1: Anterior-posterior fluoroscopic image of an injection of con-
trast medium before transforaminal injection of a mixture of tiamcino-
lone acetonide and plain bupivacaine on the right L4 nerve root.






Mean ± SD 58.2 ± 11.6
Weight:
Mean ± SD 78.5 ± 8.2
Height:
Mean ± SD 1.68 ± 0.02
Duration of pain (months):





Back pain more than leg pain 14 (30)
Leg pain more than back pain 27 (57.5)
Both equal 6 (12.5)
Numeric Pain Rating Scale:
Mean ± SD 8.49 ± 1.28
Oswestry Disability Index:
Mean ± SD 45.1 ± 11.5
Total dose of triamcinolone used: 40 mg: 5 (10.6%)
80 mg: 42 (89.4%)
Co-morbidity hypertension 15(31.9)
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respectively. Two intervertebral levels on one side, were injected
in all the 29 patients who had the injection once; two interver-
tebral levels on both sides were injected in the 13 patients
who received the injection twice, and two intervertebral levels
on both sides were injected in the 5 patients who received
the injections three times in this study.
There were 29 and 33 (62% and 70% respectively) patients who
achieved 50% or more reduction in their NPRS pain scores from
the baseline at 3 and 6 months follow-ups. Observed changes in
functional performance were concordant with changes in the
pain scores; 36 (77%) and 34 (72%) of the patients improved
10 points or more on the ODI scale at 3 and 6 months follow-
up respectively, Table 2.
Overall, statistically significant improvements were obtained and
maintained in the patients: the mean reduction in NPRS pain
score and mean improvement in ODI score, from the baseline
parameters, was 4.9 ± 1.5 and 13 ± 7 respectively, (p = 0.0001)
at the end of 6 months’ follow-up (Table 3).
There was an approximately 50% reduction in total analgesic
consumption at the end of 6 months’ follow-up (p < 0.001).
Headache after the injection of contrast medium (1 ml omnipa-
que iohexol 240 mg) occurred in one patient but resolved within
30 minutes of observation in the recovery room.
Discussion
This prospective observational study shows that patients with
lumbar radicular pain achieved significant pain relief and
improved performance following fluoroscopic-guided transfor-
aminal lumbar epidural injection of a mixture of steroid and
local anaesthetic agent. The results showed that 29 (62%) and
33 (70%) patients achieved a drop in NPRS pain score of 2.5 or
more from baseline at 3 and 6 months’ follow-up respectively.
We chose NPRS pain scores drop of 2.5 or more because
studies have shown that clinically relevant success was
deemed to have occurred when such a level of reduction is
obtained by patients.7,8 This degree of reduction in pain
scores has been shown to correspond to ‘much improved’ on
a patient global impression of change (PGIC) scale for pain.9
These findings are similar to results of some studies on transfor-
aminal lumbar epidural steroid injection for radicular pain.7–12
Previous studies on the outcomes of transforaminal and interla-
minar epidural steroid injections focused on changes in pain
intensity only13–17 and the impact of radicular pain on functional
status, with a validated questionnaire, was not evaluated. In con-
trast, the data of the present study and that of Rados et al.9
included information on pain intensity, functional impairment,
and correlation between pain and performance. Whereas, our
study evaluated the clinical effectiveness of epidural injection
in radicular pain; Rados et al. compared the efficacy of deposit-
ing the steroid into the lumbar epidural space through transfor-
aminal and interlaminar routes. The two studies revealed that
long-term (greater than six weeks) pain relief and clinically rel-
evant improvement in functional status of significant proportion
of the patients followed transforaminal steroid injections. Fur-
thermore, reductions in pain scores and enhanced performance
of daily activities obtained in the present study are similar to the
results of some previous studies.15–18 Pain relief achieved by
patients in our study facilitated compliance with physiotherapy,
which further enhanced functionality. High treatment success
rate was noticed among the patients who received more than
one injection and this was supported by the findings from the
works of Lutz et al. and Riew et al.17,19 The patients achieved
better pain control and regained their mobility faster with
improved independence. These findings could be explained
by the ability of bupivacaine to instantly block nociceptive
signals from the inflamed nerve or its roots and the slow anti-
inflammatory effect of steroid in reversing the phospholipase
A2-induced inflammatory process.
Choi et al.20 showed that lumbar transforaminal epidural steroid
injection was more effective for a contained herniated disc or
when the disc content is abutting on the spinal nerve. The evalu-
ation of the MRI findings of our patients at presentation showed
anterior impingement on the thecal membrane by the interver-
tebral disc content, which was assumed to be confined to within
the neuroforamen, a prerequisite to achieving good response in
radicular pain after steroid injection. The results of our study are
consistent with findings of a systematic review15 on the effec-
tiveness of the treatment of radicular pain with steroid
injections.
Our study assessed the effectiveness, and not the efficacy, of an
intervention. This is pertinent in that practical studies that
measure effectiveness are considered more appropriate than
explanatory trials that assess efficacy22–24 because they high-
light the benefits of such interventions. Interestingly, healthcare
policy is now being formulated from the outcomes of compara-
tive effectiveness and evidence-based medicine.25–32
Aside from the dose of steroid, clinician’s experience and train-
ing, patient selection, symptom duration, underlying pathophy-
siology, epidural steroid injection approach, and use of
fluoroscopy, vocational and socioeconomic status, and possible
psychological issues within the patient group undergoing such
conservative treatment have been identified as other factors
that may influence long-term and short-term outcomes of the
epidural steroid injections.10 In our study, fluoroscopy was
used, a transforaminal approach was employed and only
patients with radicular pain from disc herniation were treated
in order to ensure maximal benefits from the intervention.
In contrast to non-particulate steroids, triamcinolone was
chosen because its large particles, relative to red blood cells,
are slowly cleared from the spinal canal33 and thus it acts
longer on the inflamed spinal nerve leading to better pain
relief. However, serious complications can occur when particu-
late steroids act as an embolus34 during transforaminal epidural
technique causing spinal cord infarction and consequent para-
plegia. Cortical blindness,35 paraplegia,36–40 quadriplegia and
death41–43 immediately after a transforaminal technique as a
result of embolisation of particulate corticosteroid in the ver-
tebral artery or radicular artery that reinforces the spinal artery
Table 2: Summaries of Numeric Pain Rating Scale for pain and Oswestry







(Mean ± SD) (Mean ± SD)
Baseline 8.49 ± 1.28 45.1 ± 11.5
3 months 3.98 ± 1.31 33.4 ± 11.1
6 months 3.55 ± 1.46 32.4 ± 11.5
*Outcome measurements were achieved by NPRS: Numeric Pain Rating Scale; ODI:
Oswestry Disability Index.
**Based on Student’s paired t-test.
***Based on NPRS and ODI.
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respectively. Two intervertebral levels on one side, were injected
in all the 29 patients who had the injection once; two interver-
tebral levels on both sides were injected in the 13 patients
who received the injection twice, and two intervertebral levels
on both sides were injected in the 5 patients who received
the injections three times in this study.
There were 29 and 33 (62% and 70% respectively) patients who
achieved 50% or more reduction in their NPRS pain scores from
the baseline at 3 and 6 months follow-ups. Observed changes in
functional performance were concordant with changes in the
pain scores; 36 (77%) and 34 (72%) of the patients improved
10 points or more on the ODI scale at 3 and 6 months follow-
up respectively, Table 2.
Overall, statistically significant improvements were obtained and
maintained in the patients: the mean reduction in NPRS pain
score and mean improvement in ODI score, from the baseline
parameters, was 4.9 ± 1.5 and 13 ± 7 respectively, (p = 0.0001)
at the end of 6 months’ follow-up (Table 3).
There was an approximately 50% reduction in total analgesic
consumption at the end of 6 months’ follow-up (p < 0.001).
Headache after the injection of contrast medium (1 ml omnipa-
que iohexol 240 mg) occurred in one patient but resolved within
30 minutes of observation in the recovery room.
Discussion
This prospective observational study shows that patients with
lumbar radicular pain achieved significant pain relief and
improved performance following fluoroscopic-guided transfor-
aminal lumbar epidural injection of a mixture of steroid and
local anaesthetic agent. The results showed that 29 (62%) and
33 (70%) patients achieved a drop in NPRS pain score of 2.5 or
more from baseline at 3 and 6 months’ follow-up respectively.
We chose NPRS pain scores drop of 2.5 or more because
studies have shown that clinically relevant success was
deemed to have occurred when such a level of reduction is
obtained by patients.7,8 This degree of reduction in pain
scores has been shown to correspond to ‘much improved’ on
a patient global impression of change (PGIC) scale for pain.9
These findings are similar to results of some studies on transfor-
aminal lumbar epidural steroid injection for radicular pain.7–12
Previous studies on the outcomes of transforaminal and interla-
minar epidural steroid injections focused on changes in pain
intensity only13–17 and the impact of radicular pain on functional
status, with a validated questionnaire, was not evaluated. In con-
trast, the data of the present study and that of Rados et al.9
included information on pain intensity, functional impairment,
and correlation between pain and performance. Whereas, our
study evaluated the clinical effectiveness of epidural injection
in radicular pain; Rados et al. compared the efficacy of deposit-
ing the steroid into the lumbar epidural space through transfor-
aminal and interlaminar routes. The two studies revealed that
long-term (greater than six weeks) pain relief and clinically rel-
evant improvement in functional status of significant proportion
of the patients followed transforaminal steroid injections. Fur-
thermore, reductions in pain scores and enhanced performance
of daily activities obtained in the present study are similar to the
results of some previous studies.15–18 Pain relief achieved by
patients in our study facilitated compliance with physiotherapy,
which further enhanced functionality. High treatment success
rate was noticed among the patients who received more than
one injection and this was supported by the findings from the
works of Lutz et al. and Riew et al.17,19 The patients achieved
better pain control and regained their mobility faster with
improved independence. These findings could be explained
by the ability of bupivacaine to instantly block nociceptive
signals from the inflamed nerve or its roots and the slow anti-
inflammatory effect of steroid in reversing the phospholipase
A2-induced inflammatory process.
Choi et al.20 showed that lumbar transforaminal epidural steroid
injection was more effective for a contained herniated disc or
when the disc content is abutting on the spinal nerve. The evalu-
ation of the MRI findings of our patients at presentation showed
anterior impingement on the thecal membrane by the interver-
tebral disc content, which was assumed to be confined to within
the neuroforamen, a prerequisite to achieving good response in
radicular pain after steroid injection. The results of our study are
consistent with findings of a systematic review15 on the effec-
tiveness of the treatment of radicular pain with steroid
injections.
Our study assessed the effectiveness, and not the efficacy, of an
intervention. This is pertinent in that practical studies that
measure effectiveness are considered more appropriate than
explanatory trials that assess efficacy22–24 because they high-
light the benefits of such interventions. Interestingly, healthcare
policy is now being formulated from the outcomes of compara-
tive effectiveness and evidence-based medicine.25–32
Aside from the dose of steroid, clinician’s experience and train-
ing, patient selection, symptom duration, underlying pathophy-
siology, epidural steroid injection approach, and use of
fluoroscopy, vocational and socioeconomic status, and possible
psychological issues within the patient group undergoing such
conservative treatment have been identified as other factors
that may influence long-term and short-term outcomes of the
epidural steroid injections.10 In our study, fluoroscopy was
used, a transforaminal approach was employed and only
patients with radicular pain from disc herniation were treated
in order to ensure maximal benefits from the intervention.
In contrast to non-particulate steroids, triamcinolone was
chosen because its large particles, relative to red blood cells,
are slowly cleared from the spinal canal33 and thus it acts
longer on the inflamed spinal nerve leading to better pain
relief. However, serious complications can occur when particu-
late steroids act as an embolus34 during transforaminal epidural
technique causing spinal cord infarction and consequent para-
plegia. Cortical blindness,35 paraplegia,36–40 quadriplegia and
death41–43 immediately after a transforaminal technique as a
result of embolisation of particulate corticosteroid in the ver-
tebral artery or radicular artery that reinforces the spinal artery
Table 2: Summaries of Numeric Pain Rating Scale for pain and Oswestry
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3 months 3.98 ± 1.31 33.4 ± 11.1
6 months 3.55 ± 1.46 32.4 ± 11.5
*Outcome measurements were achieved by NPRS: Numeric Pain Rating Scale; ODI:
Oswestry Disability Index.
**Based on Student’s paired t-test.
***Based on NPRS and ODI.
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have been reported by some authors. In our study, headache
and lethargy, which resolved spontaneously, were observed in
two patients. Continuous fluoroscopy during and throughout
the injection of omnipaque iohexol contrast medium was uti-
lised to exclude intra-arterial flow away from the site of injection
after which the triamcinolone/bupivacaine mixture was injected
onto the target nerve roots to prevent any such serious
complications.
The weakness of this study is the lack of a placebo or control
group. However, studies on interventional procedures where
placebos were used led to conflicting outcomes due to inap-
propriate methodology.24,25 Nevertheless, the placebo agent
was found to be significantly ineffective in a properly designed
clinical trial31 and, with this finding, absence of a placebo group
in our study may not cast a serious aspersion on the clinical val-
idity of our results. For now, there is no agreed position on what
volume and dose of steroid should be injected in epidural
steroid injection.11–13
In conclusion, this study demonstrated that fluoroscopic-guided
transforaminal epidural injection of a mixture of steroid and local
anaesthetic agent is effective in controlling pain, enhancing
functionality and improving independence of patients with
lumbar radicular pain secondary to intervertebral disc
herniations.
Disclosure statement – No potential conflict of interest was
reported by the authors.
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